<DOC>
	<DOCNO>NCT02240953</DOCNO>
	<brief_summary>Prosthetic valve thrombosis serious complication high mortality morbidity . However , best anticoagulant treatment strategy patient prosthetic heart valve thrombosis fully know . In study investigator want identify effective safe regimen among different anticoagulant regimen .</brief_summary>
	<brief_title>Anticoagulation Regiments Patients With Prosthetic Heart Valve Thrombosis</brief_title>
	<detailed_description>Three different anticoagulant treatment regimens patient prosthetic heart valve non-obstructive thrombosis describe . Patients include group randomly . In first arm warfarin give patient target INR level 2.5-4 . In second arm 100 mg acetylsalicylic acid proton pump inhibitor add treatment combination warfarin . In third arm 300 mg acetylsalicylic acid proton pump inhibitor add treatment ombination warfarin . Also observational follow-up group patient prosthetic heart valve thrombosis . These patient also follow warfarin therapy INR level 2.5-4 . All patient follow serial transesophageal echocardiography perform every 6 month . Follow-up period least 6 month ( range 6-60 month ) . Informed consent take patient .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients prosthetic heart valve thrombosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Prosthetic Heart Valves</keyword>
	<keyword>Acetylsalicylic acid</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Thrombosis</keyword>
</DOC>